Letter to the Editor: Repeat Redifferentiation of Radioiodine Refractory BRAFV600E Mutated Thyroid Cancer with Dabrafenib

Thyroid. 2023 Jun;33(6):771-773. doi: 10.1089/thy.2022.0651. Epub 2023 May 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Imidazoles
  • Iodine Radioisotopes*
  • Mutation
  • Proto-Oncogene Proteins B-raf / genetics
  • Thyroid Neoplasms*

Substances

  • dabrafenib
  • Iodine Radioisotopes
  • Proto-Oncogene Proteins B-raf
  • Imidazoles
  • BRAF protein, human